Skip to main content
NIHPA Author Manuscripts logoLink to NIHPA Author Manuscripts
. Author manuscript; available in PMC: 2016 May 10.
Published in final edited form as: Thromb Haemost. 2013 Nov 28;111(4):770–772. doi: 10.1160/TH13-07-0628

Influence of membrane composition on the enhancement of factor VIIa/tissue factor activity by magnesium ions

Narjes Tavoosi 1,1, James H Morrissey 1
PMCID: PMC4862877  NIHMSID: NIHMS782048  PMID: 24285084

Dear Sirs

A number of studies have shown that the γ-carboxyglutamate-rich (GLA) domains of vitamin K-dependent clotting proteins require Ca2+ to fold properly and bind to membranes (1, 2). Although plasma contains about 1.25 mM free Ca2+ and 0.5 mM Mg2+ (3), in vitro assays of clotting factor function often employ supraphysiologic Ca2+ concentrations (2.5 to 5 mM Ca2+), and no Mg2+. Sekiya and colleagues showed that Mg2+ enhances factor IX (fIX) structure and function in combination with physiologic Ca2+ concentrations (4, 5). Subsequent reports showed that, in the presence of plasma concentrations of Ca2+, Mg2+ enhances the activity of factor VIIa (fVIIa) bound to tissue factor (TF) (6-10). The concept is that GLA domains typically bind seven or eight Ca2+ when it is the only divalent metal ion present (at supraphysiologic Ca2+ concentrations), but at plasma concentrations of Ca2+ and Mg2+, two or three of these “calcium” binding sites are actually occupied by Mg2+, with functional consequences (11). Mg2+ does not support clotting reactions in the absence of Ca2+ (12), also consistent with the notion that only a subset of the metal ion binding sites in GLA domains can be productively occupied by Mg2+.

Many studies of TF activity have employed binary mixtures of phosphatidylserine (PS) and phosphatidylcholine (PC). We previously reported that phosphatidylethanolamine (PE) supports little procoagulant activity in PE/PC liposomes, but that PE dramatically reduces the PS requirement for TF:fVIIa activity (13, 14). More recently, we reported that factor VIIa binds preferentially to phosphatidic acid (PA) and that PA enhances rates of fX activation by fVIIa alone or in complex with the isolated tissue factor ectodomain (sTF) (15). However, these studies of phospholipid synergy were conducted at saturating Ca2+ concentrations without Mg2+. Furthermore, the previous studies showing that Mg2+ enhances GLA domain function were typically performed with PS/PC liposomes or cell membranes. Therefore, the ability of Mg2+ to enhance fX activation by fVIIa has not been explored systematically as a function of phospholipid composition.

We now examine the ability of Mg2+ to enhance fVIIa function in the presence of PE or PA. Recombinant membrane-anchored TF (membTF) was reconstituted into liposomes of varying phospholipid composition (palmitoyl-oleoyl PC, palmitoyl-oleoyl PS, dioleoyl PE, and/or palmitoyl-oleoyl PA) and used to quantify rates of fX activation as previously described (15). We first measured fX activation by fVIIa on TF-liposomes composed of binary PS/PC mixtures. Consistent with studies cited above, physiologic concentrations of divalent metal ions (1.25 mM Ca2+ plus 0.5 mM Mg2+) supported slightly higher rates of fX activation by membTF:fVIIa than did supraphysiologic Ca2+ concentrations (2.5 mM Ca2+ without Mg2+) and substantially higher rates than with 1.25 mM Ca2+ without Mg2+ (Figure 1A, open diamonds, circles and squares, respectively), over the range of PS compositions tested. We replotted these data as normalized rates of fX activation in the presence of 1.25 mM Ca2+ plus 0.5 mM Mg2+, relative to rates with either 1.25 or 2. 5 mM Ca2+ (Figure 1B, open circles). The extent to which 0.5 mM Mg2+ enhanced fX activation decreased as the percent PS increased.

Figure 1. Magnesium enhances fX activation by membTF:fVIIa or sTF:fVIIa as a function of phospholipid composition.

Figure 1

A) Activation of fX by fVIIa on membTF-liposomes containing binary mixtures of PS and PC (open symbols); or containing ternary mixtures of PS, PE and PC in which the total amount of PS + PE equals 30% (balance = 70% PC; closed symbols; note that as the %PS increases, the %PE decreases in this plot). Reactions contained 1.25mM Ca2+ (□, ■); 2.5 mM Ca2+ (○, ●); or 1.25 mM Ca2+ + 0.5 mM Mg2+ (◊, ◆). Initial rates of fX activation were divided by the membTF:fVIIa concentration. B) Normalized rates of fX activation by fVIIa on membTF-liposomes (data replotted from panel A) for binary PS/PC mixtures (○) and ternary PS/PE/PC mixtures (■). Rates of fX activation at 1.25 mM Ca2+ + 0.5 mM Mg2+ were normalized to rates with either 1.25mM Ca2+ (solid lines) or 2.5 mM Ca2+ (dotted lines). Inset shows the data for normalization to 2.5 mM Ca2+ on an expanded y-axis. C) and D) Normalized rates of activation of fX by fVIIa on membTF-liposomes with increasing Ca2+ concentrations in the presence or absence of 0.5 mM Mg2+, using membTF-liposomes containing 5% PS/25% PE/70%PC (●), 20%PS/10%PE/70%PC (◆), or 30% PS/70%PC (□). In panel C, rates in the presence of varying Ca2+ + constant 0.5 mM Mg2+ were normalized to rates obtained at the same Ca2+ concentration but without Mg2+. In panel D, rates in the presence of varying Ca2+ + constant 0.5 mM Mg2+ were normalized to rates obtained at Ca2+ concentrations that equaled the total divalent cation concentration in the numerator (e.g., rates at 1.25 mM Ca2+ + 0.5 mM Mg2+ were normalized to those at 1.75 mM Ca2+ without Mg2+). (Absolute fX activation rates in this panel were 620 ± 36 min-1 for 30:70 PS:PC liposomes at 10 mM Ca2+ + 0.5 mM Mg2+, and 140 ± 3.7 min-1 for 5:25:70 PS:PE:PC liposomes at 1.25 mM Ca2+.) E) Activation of fX by sTF:fVIIa on liposomes containing binary mixtures of PS and PC (open symbols) or ternary mixtures of PS, PA and PC in which PS + PA = 30% (balance = 70% PC; closed symbols). Reactions contained 1.25mM Ca2+ (□, ■), 2.5 mM Ca2+ (○, ●), or 1.25 mM Ca2+ + 0.5 mM Mg2+ (◊, ◆). Initial rates of fX activation were divided by the sTF:fVIIa concentration. F) Normalized rates of fX activation by sTF:fVIIa on liposomes (data replotted from panel E) for ternary PS/PA/PC mixtures (◆). Rates of fX activation at 1.25 mM Ca2+ + 0.5 mM Mg2+ were normalized to rates with either 1.25mM Ca2+ (solid lines) or 2.5 mM Ca2+ (dotted lines). (In panels E and F, initial rates of fX activation by sTF:fVIIa were quantified using 100 nM fX, 10–100 pM fVIIa, 20 nM sTF, and 50 μM phospholipids. Initial rates of fX activation by fVIIa on membTF-liposomes were quantified using 100 nM fX, 1–5 pM fVIIa, and 500 pM membTF in liposomes with approximately 25 μM phospholipids. Buffer was 20mM HEPES pH 7.4, 150 mM NaCl, 0.1% bovine serum albumin, and the indicated Ca2+ and Mg2+ concentrations.) Data in all panels are mean ± standard error; n = 3 to 4.

We next investigated the influence of 0.5 mM Mg2+ on PE/PS synergy in supporting fX activation by membTF:fVIIa. When membTF was incorporated into liposomes containing ternary mixtures of phospholipid (PS + PE = 30%; balance = 70% PC), PE strongly synergized with PS under all three conditions of divalent metal ions tested (closed symbols in Figure 1A; note left-shifted PS dependence). Thus, 0.5 mM Mg2+ enhanced rates of fX activation at all combinations of PS, PE and PC tested. Replotting the data as normalized rates (Figure 1B, closed squares) showed that 0.5 mM Mg2+ enhanced fX activation on membTF-liposomes containing PE, but to an extent that was somewhat blunted compared to membTF-liposomes without PE.

To determine if the effect of Mg2+ was simply additive to that of Ca2+, we compared normalized rates of fX activation in two ways, using membTF-liposomes made with either binary PS/PC mixtures, or ternary PS/PE/PC mixtures. Rates of fX activation in mixtures of Ca2+ and Mg2+, normalized to the same Ca2+ concentrations without Mg2+ (Figure 1C), showed that the effect of 0.5 mM Mg2+ was more pronounced at lower Ca2+ concentrations. Furthermore, liposomes with low PS contents were more affected by the addition of Mg2+, compared to liposomes with high PS content. When fX activation rates in the presence of mixtures of Ca2+ and Mg2+ were normalized to Ca2+ concentrations that equaled the concentration of Ca2+ plus Mg2+, the rate enhancements were less pronounced (Figure 1D). However, rates of fX activation in the presence of Ca2+ + Mg2+ were always higher than those with just Ca2+.

PA enhances the proteolytic activity of fVIIa and sTF:fVIIa complexes (15). We prepared liposomes with binary PS/PC mixtures or ternary PS/PA/PC mixtures (PS + PA = 30%; balance = 70% PC), and tested the effect of mixtures of Ca2+ and Mg2+ on rates of fX activation by sTF:fVIIa (Figure 1E), using reaction conditions as previously described (15). When tested at 1.25 mM Ca2+, we found that Mg2+ enhanced the rate of fX activation by sTF:fVIIa on membranes containing PA in a manner similar to the enhancement of fX activation by membTF:fVIIa in PS/PE/PC liposomes. Replotting these data as normalized rates (Figure 1F) showed that, similar to PE, the effects of Mg2+ are less pronounced when PA is incorporated in membranes along with PS.

This study shows that Mg2+ enhanced the rates of fX activation by fVIIa even when the phospholipid composition varied widely. The magnitude of the rate enhancement by Mg2+ was dependent on phospholipid composition, and was highest when PS was limiting. This is consistent with the idea that GLA domains bind more weakly, and less extensively, to membranes with low PS content (14, 16), and that Mg2+ enhances the affinity of GLA domains for such low-PS membranes. Interestingly, increasing the Ca2+ concentration up to 10 mM reduced the effect of Mg2+ but did not completely mask it. This was true even for relatively high PS contents or in the presence of PE, both of which otherwise tended to blunt the contribution of Mg2+ (Figure 1C and D). One should keep in mind that in these experiments, simultaneous binding of GLA domains of two clotting factors (fX and fVIIa) to phospholipid membranes are affected by mixtures of Ca2+ and Mg2+. For membTF:fVIIa, rates of fX activation are dominated by the reversible membrane binding of fX, because fVIIa is captured efficiently by membTF under all phospholipid conditions tested (17). On the other hand, for sTF:fVIIa, the rates of fX activation are dependent on reversible membrane binding of both fX and fVIIa (as sTF:fVIIa).

Previous findings suggest that Mg2+ is better at stabilizing some of the metal ion binding sites in GLA domains than is Ca2+ alone (18), and the most solvent-accessible bound Ca2+ in GLA domains have been proposed to contribute directly to interactions with PS (14, 19). In mixtures of Ca2+ and Mg2+, two of these solvent-accessible metal ion binding sites are known to be occupied with Mg2+ (11). Our results are therefore consistent with the idea that membrane binding of GLA domains is better stabilized when these “external” metal ion binding sites are occupied with Mg2+ rather than the Ca2+.

Acknowledgments

This work was supported by US NIH grant R01 HL103999 from the National Heart, Lung and Blood Institute.

Footnotes

Conflicts of interest: None declared.

References

  • 1.Sunnerhagen M, Forsén S, Hoffrén AM, et al. Structure of the Ca2+-free GLA domain sheds light on membrane binding of blood coagulation proteins. Nat Struct Biol. 1995;2:504–9. doi: 10.1038/nsb0695-504. [DOI] [PubMed] [Google Scholar]
  • 2.Furie B, Furie BC. The molecular basis of blood coagulation. Cell. 1988;53:505–18. doi: 10.1016/0092-8674(88)90567-3. [DOI] [PubMed] [Google Scholar]
  • 3.Wang S, McDonnell EH, Sedor FA, et al. pH effects on measurements of ionized calcium and ionized magnesium in blood. Arch Pathol Lab Med. 2002;126:947–50. doi: 10.5858/2002-126-0947-PEOMOI. [DOI] [PubMed] [Google Scholar]
  • 4.Sekiya F, Yamashita T, Atoda H, et al. Regulation of the tertiary structure and function of coagulation factor IX by magnesium(II) ions. J Biol Chem. 1995;270:14325–31. doi: 10.1074/jbc.270.24.14325. [DOI] [PubMed] [Google Scholar]
  • 5.Sekiya F, Yoshida M, Yamashita T, et al. Magnesium(II) is a crucial constituent of the blood coagulation cascade - Potentiation of coagulant activities of factor IX by Mg2+ ions. J Biol Chem. 1996;271:8541–4. doi: 10.1074/jbc.271.15.8541. [DOI] [PubMed] [Google Scholar]
  • 6.van den Besselaar AMHP. Magnesium and manganese ions accelerate tissue factor-induced coagulation independently of factor IX. Blood Coagul Fibrinolysis. 2002;13:19–23. doi: 10.1097/00001721-200201000-00003. [DOI] [PubMed] [Google Scholar]
  • 7.Bajaj SP, Schmidt AE, Agah S, et al. High resolution structures of p-aminobenzamidine- and benzamidine-VIIa/soluble tissue factor: unpredicted conformation of the 192-193 peptide bond and mapping of Ca2+, Mg2+, Na+, and Zn2+ sites in factor VIIa. J Biol Chem. 2006;281:24873–88. doi: 10.1074/jbc.M509971200. [DOI] [PubMed] [Google Scholar]
  • 8.Persson E, Ostergaard A. Mg2+ binding to the Gla domain of factor X influences the interaction with tissue factor. J Thromb Haemost. 2007;5:1977–8. doi: 10.1111/j.1538-7836.2007.02661.x. [DOI] [PubMed] [Google Scholar]
  • 9.Persson E. Protein disulfide isomerase has no stimulatory chaperone effect on factor X activation by factor VIIa-soluble tissue factor. Thromb Res. 2008;123:171–6. doi: 10.1016/j.thromres.2008.04.012. [DOI] [PubMed] [Google Scholar]
  • 10.Vadivel K, Agah S, Messer AS, et al. Structural and functional studies of γ-carboxyglutamic acid domains of factor VIIa and activated Protein C: role of magnesium at physiological calcium. J Mol Biol. 2013;425:1961–81. doi: 10.1016/j.jmb.2013.02.017. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 11.Vadivel K, Bajaj SP. Structural biology of factor VIIa/tissue factor initiated coagulation. Front Biosci. 2012;17:2476–94. doi: 10.2741/4066. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 12.Prendergast FG, Mann KG. Differentiation of metal ion-induced transitions of prothrombin fragment 1. J Biol Chem. 1977;252:840–50. [PubMed] [Google Scholar]
  • 13.Neuenschwander PF, Bianco-Fisher E, Rezaie AR, et al. Phosphatidylethanolamine augments factor VIIa-tissue factor activity: enhancement of sensitivity to phosphatidylserine. Biochemistry. 1995;34:13988–93. doi: 10.1021/bi00043a004. [DOI] [PubMed] [Google Scholar]
  • 14.Tavoosi N, Davis-Harrison RL, Pogorelov TV, et al. Molecular determinants of phospholipid synergy in blood clotting. J Biol Chem. 2011;286:23247–53. doi: 10.1074/jbc.M111.251769. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 15.Tavoosi N, Smith SA, Davis-Harrison RL, et al. Factor VII and protein C are phosphatidic acid-binding proteins. Biochemistry. 2013 doi: 10.1021/bi4006368. In Press. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 16.Shaw AW, Pureza VS, Sligar SG, et al. The local phospholipid environment modulates the activation of blood clotting. J Biol Chem. 2007;282:6556–63. doi: 10.1074/jbc.M607973200. [DOI] [PubMed] [Google Scholar]
  • 17.Neuenschwander PF, Morrissey JH. Roles of the membrane-interactive regions of factor VIIa and tissue factor. The factor VIIa Gla domain is dispensable for binding to tissue factor but important for activation of factor X. J Biol Chem. 1994;269:8007–13. [PubMed] [Google Scholar]
  • 18.de Courcy B, Pedersen LG, Parisel O, et al. Understanding selectivity of hard and soft metal cations within biological systems using the subvalence concept. I. Application to blood coagulation: direct cation-protein electronic effects vs. indirect interactions through water networks. J Chem Theory Comput. 2010;6:1048–63. doi: 10.1021/ct100089s. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 19.Ohkubo YZ, Tajkhorshid E. Distinct structural and adhesive roles of Ca2+ in membrane binding of blood coagulation factors. Structure. 2008;16:72–81. doi: 10.1016/j.str.2007.10.021. [DOI] [PubMed] [Google Scholar]

RESOURCES